What Causes Rosacea in Midlife? What Are the Triggers and Best Treatments Options?

6 minute read

By: Anna Johnson|Last updated: June 5, 2026|Medically reviewed by: Sheila R. Boyle
Middle aged woman with rosacea on her cheeks, with eyes closed and her hands touching her neck. header

Summary

Rosacea is a chronic inflammatory skin condition that often emerges or worsens for women in midlife as hormonal shifts during perimenopause reduce estrogen, increasing skin sensitivity, vascular reactivity, and facial redness. Common symptoms include persistent flushing, visible blood vessels, and acne‑like papules on the cheeks and nose, often triggered by heat, alcohol, stress, UV exposure, or hot flashes. Effective management typically combines barrier‑supportive skincare with prescription treatments such as azelaic acid, metronidazole, or ivermectin, with options like doxycycline or laser therapy for persistent inflammation or visible vessels.

What is Rosacea and Why Does it Occur in Midlife

Rosacea is a chronic inflammatory skin condition that affects an estimated 16 million Americans of all ages. It can appear at any age, but many women first notice symptoms or experience worsening of symptoms in their 40s and 50s. Rosacea causes ongoing facial redness and flushing, appearance of visible blood vessels, and can also sometimes create acne-like bumps on the center of the face.

Rosacea has four subtypes: erythematotelangiectatic (redness/flushing), papulopustular (acne-like bumps), phymatous (skin thickening), and ocular (which affects the eyes). Most midlife women present with the first two types.

Estrogen supports the production of collagen, skin hydration, and elasticity. As levels fluctuate during perimenopause, the skin becomes thinner and drier, and also more reactive. Blood vessels near the surface respond more dramatically to everyday triggers. Inflammatory activity increases and for women who had an underlying susceptibility to rosacea, perimenopause can create the biological conditions where it could emerge or worsen.

“If you have rosacea and your skin is highly sensitive, we can support the overall health of your skin with our M4 skin care line, which enhances hydration and supports production of collagen improving the barrier function of the skin and decreasing the skin’s overall reactivity.” ~ Dr Sheila Boyle, Board Certified Dermatologist with Alloy.

Rosacea vs. hot flashes vs. adult acne

Rosacea can be difficult to identify because its symptoms share some similarities with other common midlife skin concerns.

Hot flashes and rosacea behave differently, but they both cause facial redness and flushing. A hot flash is sudden and systemic, and it typically starts in the chest or neck, moves upward, and fades within minutes. Rosacea redness usually lasts longer. Skin with rosacea has a baseline appearance that is often pink or red even when it is well-controlled and triggers will cause this to intensify.

Adult acne often resurfaces during perimenopause due to shifting hormone levels. These breakouts typically cluster around the jawline and chin. In contrast, bumps caused by rosacea appear most often on the cheeks and nose and are usually accompanied by flushing. Unlike acne, rosacea does not produce whiteheads or blackheads. These are inflammatory papules without the comedones typical of acne.

Other conditions, including contact dermatitis and lupus, can cause facial redness that resembles rosacea. This is one reason a proper diagnosis is important. Using acne treatments on rosacea, for example, can worsen symptoms rather than improve them.

Common triggers

Certain exposures can cause a flare of rosacea even if symptoms are being managed.

The most common rosacea triggers include:

  • Heat

  • UV Exposure

  • Alcohol (especially red wine)

  • Spicy Foods

  • Stress

  • Extremes in Temperature (such as moving from cold air into a warm room)

Hot flashes during perimenopause often become additional contributors to rosacea symptoms. They can act as direct rosacea triggers and create a negative feedback loop where hot flashes intensify rosacea redness. Stress can worsen this even more by increasing both the hot flash frequency and rosacea inflammatory activity.

Skincare That Helps vs. Skincare That Hurts

Building a rosacea friendly skincare routine during perimenopause doesn’t mean you have to buy a shelf full of elaborate products. A simple, gentle routine focused on barrier support tends to outperform a complex one.

Look for ingredients like ceramides, niacinamide, hyaluronic acid, and colloidal oatmeal. These help calm irritation and compensate for the moisture loss that comes with declining estrogen. Niacinamide has anti-inflammatory properties that can reduce underlying redness with consistent use. For sun protection, mineral filters like zinc oxide and titanium dioxide can be better tolerated than chemical alternatives in rosacea-prone skin. 

The wrong skin care products can also trigger rosacea symptoms. Alcohol-based toners, high-dose alpha hydroxy acids, benzoyl peroxide, and heavily fragranced products can all strip or irritate the skin barrier and lower its threshold which can lead to flares. Retinoids can sometimes be an option but require a conversation with your clinician. Some women tolerate  low-dose formulas, while others find them too irritating.

Each woman’s skin is different, and a product that works for one may cause irritation for another.

 Treatment Options

For persistent rosacea, skincare alone usually isn't enough. Prescription topicals are the standard of care and understanding how they work helps explain why certain combinations are more effective than others.

Azelaic acid reduces inflammation and normalizes skin cell turnover. Metronidazole targets microbial contributors and helps reduce papules and pustules. Ivermectin addresses Demodex mites which are normal skin residents that appear in significantly higher numbers in rosacea-affected skin. They contribute to the inflammatory cycle. When these actives are combined in a single formula, they target rosacea through multiple pathways at once, which is both more efficient and easier on already-sensitive skin.

“Alloy’s Rosacea face cream uniquely combines 3 active ingredients (Azelaic acid, Metronidazole and Ivermectin) to target different pathways of Rosacea so many patients with consistent use can see meaningful reduction of inflammation and redness and bumps”. ~ Dr Sheila Boyle, Board Certified Dermatologist with Alloy. 

Some products are marketed to women during midlife that use ingredients like oxymetazoline to temporarily constrict blood vessels and reduce the appearance of redness. This can offer short-term relief, but it doesn't address the underlying inflammation driving rosacea. Rebound redness is a known concern with prolonged use of these products. For women managing rosacea in midlife, treating the mechanism tends to serve them better than managing the appearance.

For more advanced cases, there are also additional options that may be considered. Low-dose or full dose doxycycline has anti-inflammatory properties and is commonly used for papulopustular rosacea. Laser and light-based therapies can address persistent visible blood vessels that topicals can't reach.

When to See a Clinician

If you're experiencing persistent redness, visible vessels, recurring bumps, or eye irritation (gritty, red, or sensitive eyes which could signal ocular rosacea), it's worth talking to a clinician. Rosacea that goes untreated can progress, and vascular changes may become more permanent over time.

Finding the right treatment means finding someone who understands the full picture. Menopausal skin has different clinical needs than it did in earlier life and should be treated on an individual basis by an expert in midlife care.

Access to care is easier than ever at Alloy with menopause-informed physicians who understand that rosacea in midlife may be occurring along with other changes and should be addressed by looking at your overall health and wellbeing.

NEWRosacea Face Cream Rx

Rosacea Face Cream Rx

Azelaic Acid + Metronidazole + Ivermectin

$33.00


Frequently Asked Questions

What causes rosacea to first emerge or worsen specifically during midlife and perimenopause?

Rosacea often surfaces or intensifies during perimenopause due to the unpredictable fluctuation and decline of estrogen levels. Estrogen is essential for maintaining collagen production, skin hydration, and elasticity; as it drops, the skin becomes thinner, drier, and significantly more reactive. This hormonal shift increases underlying inflammatory activity and causes blood vessels near the skin's surface to dilate more dramatically. For women with a genetic or underlying susceptibility, these specific biological changes create the perfect environment for rosacea symptoms to develop or flare up.

How can a person distinguish rosacea from hot flashes and adult perimenopausal acne?

While rosacea, hot flashes, and adult acne share similar traits, they behave very differently. A hot flash is a sudden, systemic event that starts in the chest or neck, moves upward, and fades within a few minutes, whereas rosacea redness is localized to the face and persists much longer as a baseline pink or red hue. Adult acne typically resurfaces around the jawline and chin due to shifting hormones and features traditional whiteheads or blackheads. In contrast, rosacea bumps cluster primarily on the cheeks and nose, are accompanied by facial flushing, and consist of inflammatory papules without any blackheads or comedones.

What are the main treatment strategies for managing midlife rosacea effectively?

Effective management requires a combination of barrier-supportive skincare and targeted prescription treatments rather than just masking the appearance. A gentle skincare routine should include anti-inflammatory and hydrating ingredients like niacinamide, ceramides, and mineral sunscreens while avoiding stripping agents like alcohol-based toners or benzoyl peroxide. For long-term control, multi-active prescription topicals combining azelaic acid, metronidazole, and ivermectin are highly effective because they simultaneously target inflammation, microbial contributors, and Demodex mites. For advanced cases, clinicians may also utilize oral doxycycline or laser therapies to target deep inflammation and persistent visible blood vessels.

References

  1. Roster K, Fleshner L, Karatas TB, Ecanow A, Sayegh A, Farabi B, et al. Menopause and common dermatoses: a systematic review. Am J Clin Dermatol. 2026;27(1):67-84. doi:10.1007/s40257-025-00931-5. PMID:41331233

  2. Wines N, Willsteed E. Menopause and the skin. Australas J Dermatol. 2001;42(3):149-158. PMID:11488706

  3. Raine-Fenning NJ, Brincat MP, Muscat-Baron Y. Skin aging and menopause: implications for treatment. Am J Clin Dermatol. 2003;4(6):371-378. PMID:12762829

  4. Yale SH, Vasudeva S, Mazza JJ, Rolak L, Arrowood J, Stichert S, et al. Disorders of flushing. Compr Ther. 2005;31(1):59-71. PMID:15793325

  5. Huguet I, Grossman A. Flushing: current concepts. Eur J Endocrinol. 2017;177(5):R219-R229. PMID:28982960

  6. Yeh MCH, Shih YC, Huang YC. Intradermal injection of botulinum toxin for erythema in rosacea: a scoping review and meta-analysis. Indian J Dermatol Venereol Leprol. 2025;91(4):448-454. PMID:39912154

Related Content

  1. https://www.myalloy.com/blog/perimenopause-skin-changes-explained-understanding-menopauses-impact-on-your

  2. https://www.myalloy.com/symptoms/acne

  3. https://www.myalloy.com/blog/its-not-puberty-its-perimenopause-lets-talk-about-acne

  4. https://www.myalloy.com/blog/expert-tips-for-menopause-skin-care-during-perimenopause-and-menopause

  5. https://www.myalloy.com/solutions/rosacea-face-cream

  6. https://www.myalloy.com/perimenopause

  7. https://myalloy.zendesk.com/hc/en-us/articles/25033598566035-How-does-Alloy-work

  8. https://www.youtube.com/watch?v=1Hqkj0p8Mik

Citations

  1. Katie Roster, Lauren Fleshner, Turkan Banu Karatas, Anna Ecanow, Alyssa Sayegh, Banu Farabi, et al.. Menopause and Common Dermatoses: A Systematic Review. Am J Clin Dermatol 2026;27(1):67-84. PMID:41331233.

    View source
  2. Marvin Chia-Han Yeh, Ya-Chu Shih, Yu-Chen Huang. Intradermal injection of botulinum toxin for erythema in rosacea: A scoping review and meta-analysis. Indian J Dermatol Venereol Leprol 2025;91(4):448-454. PMID:39912154.

    View source
  3. Steven H Yale, Shikha Vasudeva, Joseph J Mazza, Loren Rolak, Jodi Arrowood, Sara Stichert, et al.. Disorders of flushing. Compr Ther 2005;31(1):59-71. PMID:15793325.

    View source
  4. Isabel Huguet, Ashley Grossman. MANAGEMENT OF ENDOCRINE DISEASE: Flushing: current concepts. Eur J Endocrinol 2017;177(5):R219-R229. PMID:28982960.

    View source
  5. Nicholas J Raine-Fenning, Mark P Brincat, Yves Muscat-Baron. Skin aging and menopause : implications for treatment. Am J Clin Dermatol 2003;4(6):371-8. PMID:12762829.

    View source
  6. David A Sullivan, Benjamin D Sullivan, James E Evans, Frank Schirra, Hiroko Yamagami, Meng Liu, et al. Androgen deficiency, Meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci 2002;966:211-22. PMID:12114274.

    View source

Share this post

Subscribe

Go ahead, you deserve to

feel fantastic

Stay connected

Follow us